Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Trial ID or NCT#
Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.
Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma
- 1. Patients must be affected by HCC 2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2) 3. Patients must be 18 years old or older 4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure. 5. Ability to understand and the willingness to sign a written informed consent document.
- 1. Subjects under the age of 18 2. Patients currently on dialysis 3. Pregnant women
Contact us to find out if this trial is right for you.